Encapsulation of proteins and peptides into biodegradable poly(D,L-lactide-co-glycolide) microspheres prolongs and enhances antigen presentation by human dendritic cells (Q40351226)

From Wikidata

Jump to navigation Jump to search

scientific article published on 25 October 2005

Language	Label	Description	Also known as
English	Encapsulation of proteins and peptides into biodegradable poly(D,L-lactide-co-glycolide) microspheres prolongs and enhances antigen presentation by human dendritic cells	scientific article published on 25 October 2005

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Encapsulation of proteins and peptides into biodegradable poly(D,L-lactide-co-glycolide) microspheres prolongs and enhances antigen presentation by human dendritic cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

4

object named as

Elke Scandella

0 references

Marcus Groettrup

8

object named as

Marcus Groettrup

0 references

Ying Waeckerle-Men

1

object named as

Ying Waeckerle-Men

0 references

author name string

Ying Waeckerle-Men

1

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Edith Uetz-von Allmen

2

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Bruno Gander

3

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Eva Schlosser

5

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Gunter Schmidtke

6

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Hans P Merkle

7

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

language of work or name

0 references

publication date

25 October 2005

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

24

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

1847-1857

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Immunobiology of dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.032

7 January 2021

In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.032

7 January 2021

Mechanisms of antigen uptake for presentation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.032

7 January 2021

Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.032

7 January 2021

The use of dendritic cells in cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.032

7 January 2021

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.032

7 January 2021

Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.032

7 January 2021

Rapid Peptide Turnover and Inefficient Presentation of Exogenous Antigen Critically Limit the Activation of Self-Reactive CTL by Dendritic Cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.032

7 January 2021

Revisiting PLA/PLGA microspheres: an analysis of their potential in parenteral vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.032

7 January 2021

A single administration of tetanus toxoid in biodegradable microspheres elicits T cell and antibody responses similar or superior to those obtained with aluminum hydroxide

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.032

7 January 2021

Induction of sustained and elevated immune responses to weakly immunogenic synthetic malarial peptides by encapsulation in biodegradable polymer microspheres

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.032

7 January 2021

Pharmaceutical and immunological evaluation of a single-shot hepatitis B vaccine formulated with PLGA microspheres

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.032

7 January 2021

Induction of a cytotoxic T lymphocyte response by immunization with a malaria specific CTL peptide entrapped in biodegradable polymer microspheres

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.032

7 January 2021

CTL responses induced by a single immunization with peptide encapsulated in biodegradable microparticles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.032

7 January 2021

Induction of Broad and Potent Anti-Human Immunodeficiency Virus Immune Responses in Rhesus Macaques by Priming with a DNA Vaccine and Boosting with Protein-Adsorbed Polylactide Coglycolide Microparticles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.032

7 January 2021

Effective and selective immune surveillance of the brain by MHC class I-restricted cytotoxic T lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.032

7 January 2021

In vivo uptake of an experimental microencapsulated diphtheria vaccine following sub-cutaneous immunisation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.032

7 January 2021

Phenotype and functional analysis of human monocyte-derived dendritic cells loaded with biodegradable poly(lactide-co-glycolide) microspheres for immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.032

7 January 2021

MHC class I- and class II-restricted processing and presentation of microencapsulated antigens.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.032

7 January 2021

Encapsulation of peptides in biodegradable microspheres prolongs their MHC class-I presentation by dendritic cells and macrophages in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.032

7 January 2021

Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.032

7 January 2021

Specific T Helper Cell Requirement for Optimal Induction of Cytotoxic T Lymphocytes against Major Histocompatibility Complex Class II Negative Tumors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.032

7 January 2021

Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.032

7 January 2021

Presentation of a major histocompatibility complex class 1-binding peptide by monocyte-derived dendritic cells incorporating hydrophobized polysaccharide-truncated HER2 protein complex: implications for a polyvalent immuno-cell therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.032

7 January 2021

CD8+ T cell cross-priming via transfer of proteasome substrates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.032

7 January 2021

Antigen bias in T cell cross-priming

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.032

7 January 2021

Cellular protein is the source of cross-priming antigen in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.032

7 January 2021

Rapid endo-lysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.032

7 January 2021

Quantitating protein synthesis, degradation, and endogenous antigen processing

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.032

7 January 2021

Identifiers

10.1016/J.VACCINE.2005.10.032

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40351226&oldid=2074180862"